Publicaciones en colaboración con investigadores/as de University Hospital of Bern (12)

2024

  1. Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: An open-label randomized controlled trial

    International Journal of Infectious Diseases, Vol. 148

2023

  1. BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings

    Trials, Vol. 24, Núm. 1

  2. Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes

    Malaria Journal, Vol. 22, Núm. 1

2022

  1. Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial

    Clinical Infectious Diseases, Vol. 75, Núm. 1, pp. E585-E593

  2. Data on the effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19.

    CORA.Repositori de Dades de Recerca

  3. Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study

    Frontiers in Pharmacology, Vol. 13

2021

  1. Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing

    Frontiers in Pharmacology, Vol. 12

  2. Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study

    Parasites and Vectors, Vol. 14, Núm. 1

  3. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

    EClinicalMedicine, Vol. 32

  4. The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes

    PLoS Pathogens, Vol. 17, Núm. 3

2020

  1. Ivermectin and COVID-19: Keeping rigor in times of urgency

    American Journal of Tropical Medicine and Hygiene

  2. Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats

    Scientific Reports, Vol. 10, Núm. 1